Location History:
- Seoul, KR (2011)
- Mishawaka, IN (US) (2012 - 2018)
Company Filing History:
5 out of 369 
2 out of 580 
Years Active: 2011-2018
Title: Mijoon Lee: Innovator in Gelatinase Inhibitors
Introduction
Mijoon Lee is a prominent inventor based in Mishawaka, IN (US). He has made significant contributions to the field of medical research, particularly in the development of gelatinase inhibitors and prodrugs. With a total of 5 patents to his name, Lee's work focuses on addressing critical health issues related to matrix metalloproteinases (MMPs).
Latest Patents
One of Mijoon Lee's latest patents involves the invention of compounds, compositions, and methods for treating diseases, disorders, or conditions modulated by MMPs. These conditions can include stroke, neurological disorders, and ophthalmological disorders. The treatment method includes administering a compound or composition that provides a prodrug compound, which metabolizes to an active MMP inhibitor in vivo. This selective inhibition can target specific MMPs such as MMP-2, MMP-9, and MMP-14. The invention emphasizes the use of non-mutagenic prodrug compounds that effectively inhibit MMPs upon administration.
Career Highlights
Mijoon Lee has had a distinguished career, working with reputable institutions such as the University of Notre Dame Du Lac and Wayne State University. His research has significantly advanced the understanding and treatment of various medical conditions.
Collaborations
Throughout his career, Mijoon Lee has collaborated with notable colleagues, including Mayland Chang and Shahriar Mobashery. These partnerships have contributed to the success of his innovative research.
Conclusion
Mijoon Lee's work in the field of gelatinase inhibitors showcases his dedication to advancing medical science. His inventions hold the potential to improve treatment options for various diseases and disorders, making a lasting impact in the healthcare industry.